Subsequent studies have identified ANXA2 as a potential novel marker for tumor angiogenesis in HCC (Yu et al., 2007; Mohammad et al., 2008; Ji et al., 2009; Longerich et al., 2011; Zhang et al., 2012; Sun et al., 2013; Tang et al., 2019; Huang et al., 2021; Herrera-López et al., 2023). Here, ANXA2 is linked to neoplasm.